{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:12:32Z","timestamp":1786374752068,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.2459\/01.jcm.0000362041.25767.bc","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:14:25Z","timestamp":1283328865000},"page":"S27-S34","source":"Crossref","is-referenced-by-count":1,"title":["Primary percutaneous coronary intervention: different outcome for different subgroups?"],"prefix":"10.2459","volume":"10","author":[{"given":"Stefano","family":"Savonitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.jacc.2004.07.014","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction)","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.107.182616","article-title":"Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"R3-6-20210207","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0195-668X(03)00278-1","article-title":"Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study","volume":"24","author":"Di Chiara","year":"2003","journal-title":"Eur Heart J"},{"key":"R4-6-20210207","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.94.8.1826","article-title":"Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial","volume":"94","author":"White","year":"1996","journal-title":"Circulation"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/01.CIR.0000142862.98817.1F","article-title":"Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial","volume":"110","author":"Guagliumi","year":"2004","journal-title":"Circulation"},{"key":"R6-6-20210207","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9149(00)00824-9","article-title":"Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials)","volume":"86","author":"DeGeare","year":"2000","journal-title":"Am J Cardiol"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199706053362301","article-title":"A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","article-title":"Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients","volume":"27","author":"Boersma","year":"2006","journal-title":"Eur Heart J"},{"key":"R12-6-20210207","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/eurheartj\/ehn601","article-title":"Changes in management of elderly patients with myocardial infarction","volume":"30","author":"Schiele","year":"2009","journal-title":"Eur Heart J"},{"issue":"Suppl. 6","key":"R13-6-20210207","first-page":"57S","article-title":"Hospital epidemiology of ST-segment elevation myocardial infarction and feasibility of primary percutaneous coronary intervention in an interhospital network: data from a multicenter, prospective and observational study VENERE (VENEto acute myocardial infarction REgistry [in Italian]","volume":"6","author":"Olivari","year":"2005","journal-title":"Ital Heart J"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0735-1097(00)00879-2","article-title":"Cardiogenic shock complicating acute myocardial infarction\u2013-etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?","volume":"36","author":"Hochman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-6-20210207","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2005.06.072","article-title":"The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"46","author":"Yang","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R17-6-20210207","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00002512-200016030-00003","article-title":"Platelet glycoprotein IIb\/IIIa receptor antagonists and their use in elderly patients","volume":"16","author":"Mak","year":"2000","journal-title":"Drugs Aging"},{"key":"R18-6-20210207","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-6-20210207","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"R20-6-20210207","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics \u2013 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"R22-6-20210207","first-page":"e25","article-title":"Heart disease and stroke statistics \u2013 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"R23-6-20210207","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1049-3867(02)00136-6","article-title":"Are women worrying about heart disease?","volume":"12","author":"Biswas","year":"2002","journal-title":"Womens Health Issues"},{"key":"R24-6-20210207","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.107.181546","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update","volume":"115","author":"Mosca","year":"2007","journal-title":"Circulation"},{"key":"R25-6-20210207","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.CIR.0000155337.50423.C9","article-title":"Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association","volume":"111","author":"Lansky","year":"2005","journal-title":"Circulation"},{"key":"R26-6-20210207","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/hrt.2008.155804","article-title":"The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction","volume":"95","author":"Champney","year":"2009","journal-title":"Heart"},{"key":"R27-6-20210207","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.108.789800","article-title":"Sex differences in medical care and early death after acute myocardial infarction","volume":"118","author":"Jneid","year":"2008","journal-title":"Circulation"},{"key":"R28-6-20210207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/hrt.2007.138537","article-title":"Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events","volume":"95","author":"Dey","year":"2009","journal-title":"Heart"},{"key":"R29-6-20210207","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.CIR.0000160362.55803.40","article-title":"Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial","volume":"111","author":"Lansky","year":"2005","journal-title":"Circulation"},{"key":"R30-6-20210207","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.106.664979","article-title":"Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database","volume":"115","author":"Milcent","year":"2007","journal-title":"Circulation"},{"key":"R31-6-20210207","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"R32-6-20210207","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"R33-6-20210207","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/eurheartj\/ehi846","article-title":"Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterisation","volume":"27","author":"Hemmelgarn","year":"2006","journal-title":"Eur Heart J"},{"key":"R34-6-20210207","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"R35-6-20210207","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"R36-6-20210207","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ahj.2007.02.018","article-title":"Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty","volume":"153","author":"Marenzi","year":"2007","journal-title":"Am Heart J"},{"key":"R37-6-20210207","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla \u2013 its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N Engl J Med"},{"key":"R38-6-20210207","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","article-title":"Contrast agents and renal cell apoptosis","volume":"29","author":"Romano","year":"2008","journal-title":"Eur Heart J"},{"key":"R39-6-20210207","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R40-6-20210207","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"R41-6-20210207","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","article-title":"A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation","volume":"33","author":"Stevens","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R42-6-20210207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1741-7015-7-23","article-title":"Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis.","volume":"7","author":"Meier","year":"2009","journal-title":"BMC Med"},{"key":"R43-6-20210207","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2006.11.034","article-title":"The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study","volume":"49","author":"Recio-Mayoral","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R44-6-20210207","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/01.CIR.101.18.2172","article-title":"Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial","volume":"101","author":"Davidson","year":"2000","journal-title":"Circulation"},{"key":"R45-6-20210207","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.CIR.101.2.131","article-title":"Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators","volume":"101","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"R47-6-20210207","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"R48-6-20210207","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1161\/CIRCULATIONAHA.106.671644","article-title":"Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease","volume":"115","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"R49-6-20210207","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0002-9149(02)02771-6","article-title":"Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose","volume":"90","author":"Freeman","year":"2002","journal-title":"Am J Cardiol"},{"key":"R50-6-20210207","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2008.11.011","article-title":"N-acetylcysteine-enhanced contrast provides cardiorenal protection","volume":"2","author":"Meyer","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R51-6-20210207","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-200910001-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:14:46Z","timestamp":1786371286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-200910001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":46,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2459\/01.jcm.0000362041.25767.bc","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}